Table 1 Summary of antibodies employed in this case
Marker | Antibody | Source | Dilution |
|---|---|---|---|
CK7 | Anti-Human Cytokeratin 7, monoclonal, Clone OV-TL 12/30 | Dako, Glostrup, Denmark | 1:100 |
AMACR | Anti-Human P504S, rabbit monoclonal, Clone 13H4 | Dako, Glostrup, Denmark | 1:100 |
CA19-9 | Anti-CA19-9, mouse monoclonal, Clone BC/121SLE | Biocare, Concord, USA | 1:100 |
Vimentin | Anti-Vimentin, mouse monoclonal, Clone V9 | Dako, Glostrup, Denmark | 1:100 |
CD138 | Anti-Human CD138, monoclonal, Clone MI15 | Dako, Glostrup, Denmark | 1:50 |
CD10 | Anti-CD10, rabbit monoclonal, Clone SP67 | Roche, Basel, Switzerland | 1:1 (prediluted) |
p63 | Anti-p63, mouse monoclonal, Clone BC4A4 | Biocare, Concord, USA | 1:200 |
PSA | Anti-Human Prostate-Specfic Antigen, Clone ER-PR8 | Dako, Glostrup, Denmark | 1:50 |
PAX8 | Anti-Pax8, mouse monoclonal, Clone BCl2 | Biocare, Concord, USA | 1:1 (prediluted) |
PAX2 | Anti-Pax2, rabbit monoclonal, Clone EP3251 | Abcam, Cambridge, UK | 1:1000 |
Ki-67 | Anti-Ki67, rabbit monoclonal, Clone 30-9 | Roche, Basel, Switzerland | 1:1 (prediluted) |